[English] 日本語

- EMDB-43648: Kappa opioid receptor:Galphai protein in complex with inverse ago... -
+
Open data
-
Basic information
Entry | ![]() | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Title | Kappa opioid receptor:Galphai protein in complex with inverse agonist JDTic, Original map receptor | |||||||||
![]() | Original map, KOR:Gi:scFv16:JDTic receptor | |||||||||
![]() |
| |||||||||
![]() | G protein coupled receptor / Opioid receptor / MEMBRANE PROTEIN | |||||||||
Function / homology | ![]() response to acrylamide / adenylate cyclase-inhibiting opioid receptor signaling pathway / dynorphin receptor activity / regulation of saliva secretion / negative regulation of luteinizing hormone secretion / sensory perception of temperature stimulus / positive regulation of eating behavior / G protein-coupled opioid receptor activity / G protein-coupled opioid receptor signaling pathway / positive regulation of dopamine secretion ...response to acrylamide / adenylate cyclase-inhibiting opioid receptor signaling pathway / dynorphin receptor activity / regulation of saliva secretion / negative regulation of luteinizing hormone secretion / sensory perception of temperature stimulus / positive regulation of eating behavior / G protein-coupled opioid receptor activity / G protein-coupled opioid receptor signaling pathway / positive regulation of dopamine secretion / sensory perception / positive regulation of potassium ion transmembrane transport / receptor serine/threonine kinase binding / maternal behavior / conditioned place preference / neuropeptide binding / positive regulation of p38MAPK cascade / eating behavior / behavioral response to cocaine / neuropeptide signaling pathway / estrous cycle / MECP2 regulates neuronal receptors and channels / axon terminus / sensory perception of pain / T-tubule / Peptide ligand-binding receptors / sarcoplasmic reticulum / locomotory behavior / response to insulin / response to nicotine / cellular response to glucose stimulus / adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway / response to estrogen / synaptic vesicle membrane / presynaptic membrane / cellular response to lipopolysaccharide / G alpha (i) signalling events / phospholipase C-activating G protein-coupled receptor signaling pathway / chemical synaptic transmission / defense response to virus / perikaryon / response to ethanol / postsynaptic membrane / neuron projection / immune response / dendrite / mitochondrion / nucleoplasm / membrane / plasma membrane / cytosol Similarity search - Function | |||||||||
Biological species | ![]() | |||||||||
Method | single particle reconstruction / cryo EM / Resolution: 3.0 Å | |||||||||
![]() | Gati C / Motiwala Z / Tyson AS / Styrpejko D / Han GW / Khan S / Ramos-Gonzalez N / Shenvi R / Majumdar S | |||||||||
Funding support | ![]()
| |||||||||
![]() | ![]() Title: Molecular mechanisms of inverse agonism via κ-opioid receptor-G protein complexes. Authors: Aaliyah S Tyson / Saif Khan / Zenia Motiwala / Gye Won Han / Zixin Zhang / Mohsen Ranjbar / Daniel Styrpejko / Nokomis Ramos-Gonzalez / Stone Woo / Kelly Villers / Delainey Landaker / Terry ...Authors: Aaliyah S Tyson / Saif Khan / Zenia Motiwala / Gye Won Han / Zixin Zhang / Mohsen Ranjbar / Daniel Styrpejko / Nokomis Ramos-Gonzalez / Stone Woo / Kelly Villers / Delainey Landaker / Terry Kenakin / Ryan Shenvi / Susruta Majumdar / Cornelius Gati / ![]() Abstract: Opioid receptors, a subfamily of G protein-coupled receptors (GPCRs), are key therapeutic targets. In the canonical GPCR activation model, agonist binding is required for receptor-G protein complex ...Opioid receptors, a subfamily of G protein-coupled receptors (GPCRs), are key therapeutic targets. In the canonical GPCR activation model, agonist binding is required for receptor-G protein complex formation, while antagonists prevent G protein coupling. However, many GPCRs exhibit basal activity, allowing G protein association without an agonist. The pharmacological impact of agonist-free receptor-G protein complexes is poorly understood. Here we present biochemical evidence that certain κ-opioid receptor (KOR) inverse agonists can act via KOR-G protein complexes. To investigate this phenomenon, we determined cryo-EM structures of KOR-G protein complexes with three inverse agonists: JDTic, norBNI and GB18, corresponding to structures of inverse agonist-bound GPCR-G protein complexes. Remarkably, the orthosteric binding pocket resembles the G protein-free 'inactive' receptor conformation, while the receptor remains coupled to the G protein. In summary, our work challenges the canonical model of receptor antagonism and offers crucial insights into GPCR pharmacology. | |||||||||
History |
|
-
Structure visualization
Supplemental images |
---|
-
Downloads & links
-EMDB archive
Map data | ![]() | 32.3 MB | ![]() | |
---|---|---|---|---|
Header (meta data) | ![]() ![]() | 21 KB 21 KB | Display Display | ![]() |
Images | ![]() | 72.2 KB | ||
Filedesc metadata | ![]() | 5.6 KB | ||
Others | ![]() ![]() ![]() | 59.6 MB 59.4 MB 59.4 MB | ||
Archive directory | ![]() ![]() | HTTPS FTP |
-Related structure data
Related structure data | ![]() 8vveC ![]() 8vvfC ![]() 8vvgC ![]() 9d61C ![]() 46609 C: citing same article ( |
---|---|
Similar structure data | Similarity search - Function & homology ![]() |
-
Links
EMDB pages | ![]() ![]() |
---|---|
Related items in Molecule of the Month |
-
Map
File | ![]() | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annotation | Original map, KOR:Gi:scFv16:JDTic receptor | ||||||||||||||||||||||||||||||||||||
Projections & slices | Image control
Images are generated by Spider. | ||||||||||||||||||||||||||||||||||||
Voxel size | X=Y=Z: 1.294 Å | ||||||||||||||||||||||||||||||||||||
Density |
| ||||||||||||||||||||||||||||||||||||
Symmetry | Space group: 1 | ||||||||||||||||||||||||||||||||||||
Details | EMDB XML:
|
-Supplemental data
-Additional map: Sharpened map, KOR:Gi:scFv16:JDTic receptor
File | emd_43648_additional_1.map | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annotation | Sharpened map, KOR:Gi:scFv16:JDTic receptor | ||||||||||||
Projections & Slices |
| ||||||||||||
Density Histograms |
-Half map: Original half map A, KOR:Gi:scFv16:JDTic receptor
File | emd_43648_half_map_1.map | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annotation | Original half map A, KOR:Gi:scFv16:JDTic receptor | ||||||||||||
Projections & Slices |
| ||||||||||||
Density Histograms |
-Half map: Original half map B, KOR:Gi:scFv16:JDTic receptor
File | emd_43648_half_map_2.map | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annotation | Original half map B, KOR:Gi:scFv16:JDTic receptor | ||||||||||||
Projections & Slices |
| ||||||||||||
Density Histograms |
-
Sample components
-Entire : Kappa opioid receptor in complex with heterotrimeric G protein (G...
Entire | Name: Kappa opioid receptor in complex with heterotrimeric G protein (Gai/b/g) and inverse agonist JDTic |
---|---|
Components |
|
-Supramolecule #1: Kappa opioid receptor in complex with heterotrimeric G protein (G...
Supramolecule | Name: Kappa opioid receptor in complex with heterotrimeric G protein (Gai/b/g) and inverse agonist JDTic type: complex / ID: 1 / Parent: 0 / Macromolecule list: all |
---|---|
Source (natural) | Organism: ![]() |
Molecular weight | Theoretical: 130 kDa/nm |
-Macromolecule #1: Kappa opioid receptor
Macromolecule | Name: Kappa opioid receptor / type: protein_or_peptide / ID: 1 / Enantiomer: DEXTRO |
---|---|
Source (natural) | Organism: ![]() |
Recombinant expression | Organism: ![]() |
Sequence | String: MDSPIQIFRG EPGPTCAPSA CLPPNSSAWF PGWAEPDSNG SAGSEDAQLE PAHISPAIPV IITAVYSVV FVVGLVGNSL VMFVIIRYTK MKTATNIYIF NLALADALVT TTMPFQSTVY L MNSWPFGD VLCKIVISID YYNMFTSIFT LTMMSVDRYI AVCHPVKALD ...String: MDSPIQIFRG EPGPTCAPSA CLPPNSSAWF PGWAEPDSNG SAGSEDAQLE PAHISPAIPV IITAVYSVV FVVGLVGNSL VMFVIIRYTK MKTATNIYIF NLALADALVT TTMPFQSTVY L MNSWPFGD VLCKIVISID YYNMFTSIFT LTMMSVDRYI AVCHPVKALD FRTPLKAKII NI CIWLLSS SVGISAIVLG GTKVREDVDV IECSLQFPDD DYSWWDLFMK ICVFIFAFVI PVL IIIVCY TLMILRLKSV RLLSGSREKD RNLRRITRLV LVVVAVFVVC WTPIHIFILV EALG STSHS TAALSSYYFC IALGYTNSSL NPILYAFLDE NFKRCFRDFC FPLKMRMERQ STSRV RNTV QDPAYLRDID GMNKPV UniProtKB: Kappa-type opioid receptor |
-Experimental details
-Structure determination
Method | cryo EM |
---|---|
![]() | single particle reconstruction |
Aggregation state | particle |
-
Sample preparation
Concentration | 18 mg/mL | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Buffer | pH: 7.5 Component:
| ||||||||||||
Grid | Model: Quantifoil / Material: GOLD / Mesh: 200 / Support film - Material: GOLD / Support film - topology: HOLEY ARRAY | ||||||||||||
Vitrification | Cryogen name: ETHANE / Chamber humidity: 90 % / Chamber temperature: 298 K / Instrument: FEI VITROBOT MARK IV |
-
Electron microscopy
Microscope | FEI TITAN KRIOS |
---|---|
Specialist optics | Energy filter - Name: GIF Bioquantum / Energy filter - Slit width: 20 eV |
Image recording | Film or detector model: GATAN K3 BIOQUANTUM (6k x 4k) / Number grids imaged: 1 / Average electron dose: 60.0 e/Å2 |
Electron beam | Acceleration voltage: 300 kV / Electron source: ![]() |
Electron optics | C2 aperture diameter: 50.0 µm / Calibrated magnification: 105000 / Illumination mode: FLOOD BEAM / Imaging mode: BRIGHT FIELD / Cs: 2.7 mm / Nominal defocus max: -25.0 µm / Nominal defocus min: -15.0 µm |
Sample stage | Specimen holder model: FEI TITAN KRIOS AUTOGRID HOLDER / Cooling holder cryogen: NITROGEN |
Experimental equipment | ![]() Model: Titan Krios / Image courtesy: FEI Company |